Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Leigh

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Neuroepidemiology|November 29, 2008
Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population studyKirsten M Scott, Kumar Abhinav, Biba R Stanton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Archives of Neurology|January 14, 2009
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosisBiba R Stanton, Daisy Shinhmar, Martin R Turner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2014
Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population studyNaomi H Martin, Sabine Landau, Anna Janssen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 20, 2014
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosisAshley R Jones, Naheed Jivraj, Rubika Balendra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2019
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
The Journal of Biological Chemistry|July 29, 2005
ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowthElizabeth L Tudor, Michael S Perkinton, Anja Schmidt, et al.
Annals of Neurology|July 3, 2003
Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosisAmmar Al-Chalabi, Margaret D Scheffler, Bradley N Smith, et al.
American Journal of Human Genetics|July 4, 2003
Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16qDeborah M Ruddy, Matthew J Parton, Ammar Al-Chalabi, et al.
Neurobiology of Aging|August 22, 2021
Altered network stability in progressive supranuclear palsyDavid J Whiteside, P Simon Jones, Boyd C P Ghosh, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Neuroepidemiology|November 29, 2008
Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population studyKirsten M Scott, Kumar Abhinav, Biba R Stanton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Archives of Neurology|January 14, 2009
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosisBiba R Stanton, Daisy Shinhmar, Martin R Turner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2014
Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population studyNaomi H Martin, Sabine Landau, Anna Janssen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 20, 2014
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosisAshley R Jones, Naheed Jivraj, Rubika Balendra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2019
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
The Journal of Biological Chemistry|July 29, 2005
ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowthElizabeth L Tudor, Michael S Perkinton, Anja Schmidt, et al.
Annals of Neurology|July 3, 2003
Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosisAmmar Al-Chalabi, Margaret D Scheffler, Bradley N Smith, et al.
American Journal of Human Genetics|July 4, 2003
Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16qDeborah M Ruddy, Matthew J Parton, Ammar Al-Chalabi, et al.
Neurobiology of Aging|August 22, 2021
Altered network stability in progressive supranuclear palsyDavid J Whiteside, P Simon Jones, Boyd C P Ghosh, et al.
Pageof 15